financetom
Business
financetom
/
Business
/
DaVita Q1 Adjusted Earnings Drop, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DaVita Q1 Adjusted Earnings Drop, Revenue Rises
May 26, 2025 6:15 AM

04:18 PM EDT, 05/12/2025 (MT Newswires) -- DaVita ( DVA ) reported Q1 adjusted earnings late Monday of $2.00 per diluted share, down from $2.26 a year earlier.

Analysts polled by FactSet expected $1.95.

Revenue for the quarter ended March 31 was $3.22 billion, up from $3.07 billion a year earlier. Four analysts surveyed by FactSet expected $3.21 billion.

For 2025, the company reaffirmed its guidance for adjusted EPS of $10.20 to $11.30. Analysts surveyed by FactSet expect $11.03.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US
Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US
Jun 22, 2021
Dr Reddy's Icosapent Ethyl is available in 1 gram capsules in a bottle count size of 120's count. It is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.
Venky’s to benefit from increased soya, maize production; wants to be known as a protein co
Venky’s to benefit from increased soya, maize production; wants to be known as a protein co
Jun 22, 2021
Despite the turbulence caused by COVID and bird flu, the company has recorded good performance, owing to diversification of its portfolio, said Prasanna Pedgaonkar, General Manager-Poultry at Venky’s India, in an interview with CNBC-TV18.
Sun Pharma settles patent litigation with Celgene Corporation for cancer drug Revlimid
Sun Pharma settles patent litigation with Celgene Corporation for cancer drug Revlimid
Jun 22, 2021
Drug major Sun Pharmaceutical on Tuesday said the company has reached an agreement with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb, to resolve the patent litigation regarding the generic version of Revlimid (lenalidomide capsules) in the US. Revlimid is used in the treatment of cancer.
Restaurant associations urge Maha govt, BMC to allow Mumbai re-opening as per guideline
Restaurant associations urge Maha govt, BMC to allow Mumbai re-opening as per guideline
Jun 22, 2021
Maharashtra government is planning to meet district administrations to discuss relaxations for restaurants and shops, sources say. In an interview with CNBC-TV18, Anurag Katriar, president of the National Restaurant Association of India (NRAI), and Anjan Chatterjee, CMD of Speciality Restaurants, spoke at length about the relaxation norms.
Copyright 2023-2026 - www.financetom.com All Rights Reserved